Total Payments
$3,970
2024 Payments
$43.50
Companies
23
Transactions
298
Medicare Patients
549
Medicare Billing
$65,186
Payment Breakdown by Category
Food & Beverage$3,928 (98.9%)
Education$42.04 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,928 | 295 | 98.9% |
| Education | $42.04 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $683.75 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $634.42 | 43 | $0 (2020) |
| GlaxoSmithKline, LLC. | $592.63 | 48 | $0 (2020) |
| Novo Nordisk Inc | $407.89 | 32 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $304.72 | 23 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $240.07 | 21 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $185.86 | 11 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $159.41 | 9 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $129.75 | 11 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $120.96 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.50 | 2 | PFIZER INC. ($43.50) |
| 2020 | $166.66 | 11 | AstraZeneca Pharmaceuticals LP ($44.51) |
| 2019 | $1,281 | 100 | AstraZeneca Pharmaceuticals LP ($270.37) |
| 2018 | $1,310 | 97 | GlaxoSmithKline, LLC. ($265.17) |
| 2017 | $1,169 | 88 | PFIZER INC. ($217.22) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/28/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/12/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Respiratory | ||||||
| 02/21/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Neuroscience | ||||||
| 02/05/2020 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: VACCINE | ||||||
| 02/04/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: RESPIRATORY | ||||||
| 01/28/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/23/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Respiratory | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/07/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Diabetes | ||||||
| 12/16/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 12/16/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: Diabetes | ||||||
| 12/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: Diabetes | ||||||
| 12/09/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.37 | General |
| Category: Cardiovascular | ||||||
| 11/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/18/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Virology & Specialty Care | ||||||
| 11/13/2019 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: VACCINE | ||||||
| 11/13/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/11/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: GASTROINTESTINAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 107 | 232 | $41,089 | $14,292 |
| 2022 | 2 | 126 | 256 | $43,464 | $15,943 |
| 2021 | 2 | 133 | 330 | $56,887 | $20,198 |
| 2020 | 3 | 183 | 330 | $50,644 | $14,753 |
Total Patients
549
Total Services
1,148
Medicare Billing
$65,186
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 198 | $36,849 | $12,829 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 34 | $4,240 | $1,462 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 216 | $38,664 | $14,032 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 40 | $4,800 | $1,911 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 293 | $52,447 | $18,329 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 37 | $4,440 | $1,869 | 42.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 240 | $42,960 | $12,092 | 28.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 49 | $5,880 | $1,536 | 26.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 38 | 41 | $1,804 | $1,125 | 62.4% |
About Dr. John Mcguire, MD
Dr. John Mcguire, MD is a Family Medicine healthcare provider based in Victor, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407965510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mcguire, MD has received a total of $3,970 in payments from pharmaceutical and medical device companies, with $43.50 received in 2024. These payments were reported across 298 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,928).
As a Medicare-enrolled provider, Mcguire has provided services to 549 Medicare beneficiaries, totaling 1,148 services with total Medicare billing of $65,186. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Victor, NY
- Active Since 08/30/2006
- Last Updated 03/21/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1407965510
Products in Payments
- FARXIGA (Drug) $327.09
- CHANTIX (Drug) $306.44
- Tresiba (Drug) $247.02
- ELIQUIS (Drug) $242.57
- SYMBICORT (Drug) $207.90
- XARELTO (Drug) $205.07
- TRELEGY ELLIPTA (Drug) $204.80
- JANUVIA (Drug) $188.09
- ENTRESTO (Drug) $159.41
- BREO (Drug) $121.24
- ANORO (Drug) $114.97
- Trintellix (Drug) $102.66
- BEXSERO (Biological) $95.39
- JARDIANCE (Drug) $94.22
- TOUJEO (Drug) $90.88
- Aimovig (Biological) $85.18
- ROTATEQ (Biological) $77.94
- SOLIQUA (Drug) $65.45
- Ozempic (Drug) $57.48
- TRULICITY (Drug) $56.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.